- Home
- NAMS vs MHO Comparison
NAMS vs MHO Comparison
Compare NAMS & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | MHO |
|---|---|---|
| Founded | 2019 | 1976 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NAMS | MHO |
|---|---|---|
| Price | $30.14 | $123.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $46.75 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 865.3K | 194.5K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.74 |
| Revenue | N/A | ★ $4,417,781,000.00 |
| Revenue This Year | $25.64 | $0.66 |
| Revenue Next Year | $530.85 | $6.97 |
| P/E Ratio | ★ N/A | $8.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.06 | $100.22 |
| 52 Week High | $42.00 | $158.92 |
Technical Indicators
Market Signals| Indicator | NAMS | MHO |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 33.42 |
| Support Level | $29.73 | $118.20 |
| Resistance Level | $31.72 | $140.41 |
| Average True Range (ATR) | 1.62 | 3.95 |
| MACD | -0.07 | -1.48 |
| Stochastic Oscillator | 50.55 | 21.39 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.